Published on 10 May 2024 on GuruFocus.com via Yahoo Finance
Insider Sale: CEO Ameet Mallik Sells 29,731 Shares of ADC Therapeutics SA (ADCT)
On May 7, 2024, Ameet Mallik, Chief Executive Officer of ADC Therapeutics SA (NYSE:ADCT), sold 29,731 shares of the company. The transaction was filed on the same day with the SEC.
Warning! GuruFocus has detected 6 Warning Signs with ADCT.
ADC Therapeutics SA is a biotechnology firm focused on the development of antibody-drug conjugates (ADCs) for the treatment of both solid and hematological cancers. The company leverages its proprietary technology to create ADCs that are designed to overcome major challenges associated with existing cancer therapies.